D-0173-2021 Class II Terminated
FDA drug recall D-0173-2021 was initiated by Ascend Laboratories LLC on Nov 24, 2020 and is designated Class II. Reason for recall: Failed Dissolution Specifications; Out of Specification (low) results were obtained. The recall status is terminated (terminated Apr 11, 2023). Affected quantity: 1200 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 9, 2020
- Initiation Date
- Nov 24, 2020
- Termination Date
- Apr 11, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1200 bottles
Product description
Tizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by Alkem Laboratories Ltd, Mumbai - 400 013, INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC: 67877-614-15.
Reason for recall
Failed Dissolution Specifications; Out of Specification (low) results were obtained.
Distribution pattern
MI
Code information
Lot #19143017, Exp. 05/31/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0173-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026